What is the official website of Amgen France ?

The official website of Amgen France is http://www.amgen.fr.

What is Amgen France's cybersecurity risk score?

Amgen France has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Amgen France experienced?

According to Rankiteo, Amgen France currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Amgen France been affected by any supply chain cyber incidents ?

According to Rankiteo, Amgen France has been affected by a supply chain cyber incident involving Central Data Storage, with the incident ID AMGCEN1785529893.

Does Amgen France have SOC 2 Type 1 certification ?

According to Rankiteo, Amgen France is not certified under SOC 2 Type 1.

Does Amgen France have SOC 2 Type 2 certification ?

According to Rankiteo, Amgen France does not hold a SOC 2 Type 2 certification.

Does Amgen France comply with GDPR ?

According to Rankiteo, Amgen France is not listed as GDPR compliant.

Does Amgen France have PCI DSS certification ?

According to Rankiteo, Amgen France does not currently maintain PCI DSS compliance.

Does Amgen France comply with HIPAA ?

According to Rankiteo, Amgen France is not compliant with HIPAA regulations.

Does Amgen France have ISO 27001 certification ?

According to Rankiteo,Amgen France is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Amgen France operate in ?

Amgen France operates primarily in the Biotechnology Research industry.

How many employees does Amgen France have ?

Amgen France employs approximately None employees people worldwide.

Does Amgen France own any subsidiaries ?

Amgen France presently has no subsidiaries across any sectors.

How many LinkedIn followers does Amgen France have ?

Amgen France's official LinkedIn profile has approximately 17,068 followers.

What is the NAICS classification code for Amgen France ?

Amgen France is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Amgen France have a Crunchbase profile ?

No, Amgen France does not have a profile on Crunchbase.

Does Amgen France have a LinkedIn profile ?

Yes, Amgen France maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/amgen-france.

How many cybersecurity incidents has Amgen France experienced ?

As of October 10, 2026, Rankiteo reports that Amgen France has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Amgen France have ?

Amgen France has an estimated 4,781 peer or competitor companies worldwide.

What types of cybersecurity incidents has Amgen France faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Amgen France

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Amgen France Vendor Cyber Rating & Cyber Score

amgen.fr

Add Your Compliance Badge

Amgen utilise les ressources de la biologie pour découvrir, développer et assurer la production de médicaments innovants destinés à traiter des patients atteints de maladies graves. Cette approche repose sur des technologies de pointe, telles que la génétique humaine, qui permettent de caractériser les mécanismes moléculaires à l’origine des maladies. Amgen focalise ses recherches sur les pathologies pour lesquelles les besoins médicaux restent importants. Pionnier des biotechnologies médicales depuis 1980, Amgen est devenue l'une des plus importante entreprise indépendante dans ce domaine, nous développons des médicaments prometteurs et continuons de faire progresser la prise en charge des patients à travers le monde. Pour plus

Amgen France

Amgen France CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Amgen

Breach

7/2026

Central Data St...

AMGCEN178552989...

Amgen France

Breach

4/2021

AMG552072825

Loading…

A.I.

Amgen France Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Amgen France

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Amgen France in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Amgen France in 2026.

Incident Types Amgen France vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Amgen France in 2026.

Incident History - Amgen France (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Amgen France Subsidiaries

Amgen France

Biotechnology Research

Website: http://www.amgen.fr

Company Size: None employees

AmgenBiotechnology Research

Amgen OncologyBiotechnology Research

Amgen DeutschlandBiotechnology

Amgen NetherlandsBiotechnologisch onderzoek

Loading…

Amgen France Similar Companies

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Loading…

NEWS

Amgen France CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-22061

SUMMARY

Trident versions v25.02.1 through v26.06.1 are susceptible to a vulnerability that could allow an authenticated attacker with access to debug logs to view LUKS passphrases or SMB Active Directory credentials.

Published

Date2026-10-09

Updated

Date2026-10-09

RISK INFORMATION (Score: )

cvss4

Base Score: 8.2

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://security.netapp.com/advisory/NTAP-20261009-0026

CVE-2026-108269

SUMMARY

Remote Attestation TLS Clients provides multi-language utilities for verifying attested TLS connections. Prior to 0.5.0, the Rust and Go RA-TLS challenge verifiers accepted quote ReportData that was bound to the certificate public key and client nonce but not to the active TLS session before permitting application traffic. An attacker who obtained an enclave TLS private key could relay a genuine quote onto another connection, causing the clients to accept an attacker-terminated connection as the attested enclave. This issue is fixed in 0.5.0.

Published

Date2026-10-09

Updated

Date2026-10-09

RISK INFORMATION (Score: )

cvss4

Base Score: 9.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-108268

SUMMARY

Enclave OS Virtual runs container workloads inside confidential virtual machines with end-to-end attestation. Prior to tdx-v0.2.43 and tdx-gpu-v0.6.27, the TDX/GPU RA-TLS certificate issuer placed the certificate public-key hash and client nonce in quote ReportData but omitted a value bound to the active TLS session. An attacker who obtained an enclave TLS private key could relay a genuine quote onto another connection, causing a relying party to accept an attacker-terminated connection as the attested enclave. This issue is fixed in tdx-v0.2.43 and tdx-gpu-v0.6.27.

Published

Date2026-10-09

Updated

Date2026-10-09

RISK INFORMATION (Score: )

cvss4

Base Score: 9.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-108267

SUMMARY

Privasys Go is a maintained fork of the Go programming language that adds RA-TLS support to crypto/tls. Prior to privasys-v0.5.1-go1.26.5, challenge-mode RA-TLS certificates bound quote ReportData to the certificate public key and client nonce but not to the active TLS session. An attacker who obtained an enclave TLS private key could relay a genuine quote onto another connection, causing a relying party to accept a handshake terminated by the attacker as an attested enclave connection. This issue is fixed in privasys-v0.5.1-go1.26.5.

Published

Date2026-10-09

Updated

Date2026-10-09

RISK INFORMATION (Score: )

cvss4

Base Score: 9.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-92705

SUMMARY

Aegisub is a cross-platform advanced subtitle editor. From 3.2.0 to 3.4.2, Aegisub automatically loads Automation scripts referenced by `Automation Scripts` metadata in `ASS` subtitle projects without asking whether the user trusts the scripts or their authors. An attacker can distribute a crafted `ASS` file together with a referenced malicious Automation script, and opening the `AS` file executes arbitrary code with the privileges of the Aegisub process. From 3.4.0 to 3.4.2, inconsistent handling of embedded `NUL` characters between extension validation and filesystem operations additionally allows a crafted `ASS/Lua` polyglot to reference and execute itself as a single-file variant. The vulnerability is fixed in Aegisub 3.5.0.

Published

Date2026-10-09

Updated

Date2026-10-09

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Amgen France Vendor Cyber Rating & Cyber Score

Amgen France A.I CyberSecurity Scoring

Amgen France CyberSecurity News & History

Amgen France Company Scoring based on AI Models